The dNOS locus encodes a family of proteins including DNOS1, a full length enzymatically active form, which bears extensive similarity to its mammalian sequelogs [9], and whose activity is dependent on the same cofactors as vertebrate NOS proteins. dNOS1 is first expressed in the embryo and later in the larva, pupa and adult. Our experimental approach was to generate point mutations and test them against a deficiency in the dNOS locus. To generate the deficiency, we mobilized the l(2)k08405 P-element located 11 kb proximal to dNOS. This produced a 20 kb deletion, Df(2L)69F, which is homozygous lethal and spans part of the dNOS transcription unit along with five flanking genes (Figure 1) . Flies heterozygous for this deletion showed reduced levels of DNOS protein and half the wild-type level of NOS activity ( Figure 1B,C) . No novel NOS-related peptides or transcripts were revealed by Western and Northern analyses of flies bearing the deficiency chromosome (data not shown). We next generated 4855 mutant lines, using ethyl methanesulfonate (EMS), and screened them for lethality by complementation with the deficiency chromosome. 32 lethal mutations, falling into five complementation groups, were identified (Supplemental Data). Extracts from one of these mutants, dNOS C , revealed reduced levels of NOS enzymatic activity (Figure 2) , suggesting that this strain carries a null mutation in dNOS. We performed five generations of outcrossing of the mutant to wild-type flies, replacing at least 95% of the original mutated genome [10], and found that in this new genetic background the mutated gene still conferred larval lethality to homozygotes, indicating that the effect is not due to a secondary mutation. Sequence analysis of genomic DNA from the dNOS C strain identified a single G to A transition corresponding to position 1942 of the dNOS1 mRNA, creating a glycine (Gly) to glutamic acid (Glu) substitution at position 585 of DNOS1 ( Figure  2B ). We expressed the mutated DNOS1 protein in cell culture and found that its enzymatic activity was abolished even though the protein was expressed at the same level as wild-type DNOS1 in this assay (Figure 2C,D) . Flies homozygous for the DNOSGly585Glu mutation die during late embryonic and larval stages, demonstrating that DNOS 
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